Inhibition of MicroRNA Sensitizes 3D Breast Cancer Microtissues to Radiation Therapy



Similar documents
Notch 1 -dependent regulation of cell fate in colorectal cancer

Application Note No. 2 / July Quantitative Assessment of Cell Quality, Viability and Proliferation. System

Micro RNAs: potentielle Biomarker für das. Blutspenderscreening

岑 祥 股 份 有 限 公 司 技 術 專 員 費 軫 尹

2.1.2 Characterization of antiviral effect of cytokine expression on HBV replication in transduced mouse hepatocytes line

TOOLS sirna and mirna. User guide

Chapter 18: Applications of Immunology

OriGene Technologies, Inc. MicroRNA analysis: Detection, Perturbation, and Target Validation

Superior TrueMAB TM monoclonal antibodies for the recognition of proteins native epitopes

Supplementary Figure 1.

Understanding the immune response to bacterial infections

MicroRNA formation. 4th International Symposium on Non-Surgical Contraceptive Methods of Pet Population Control

Cell Cycle Phase Determination Kit

2/5

ab Protein Sumoylation Assay Ultra Kit

HP8 herbal formula selectively inhibits prostate cancer cell line proliferation by inducing G2/M cell cycle arrest.

M. Ugolini 1,2, G. Babini 1,2, G. Baiocco 1,2, D. Cappelletti 1,2, L. Mariotti 1,2, J. Morini 1,2,3 and A. Ottolenghi 1,2

Selection of Cell Lines for Manufacturing Therapeutic Antibodies by Flow Cytometric Cell Sorting. Andrew Racher Lonza Biologics

RNAi Shooting the Messenger!

Head of College Scholars List Scheme. Summer Studentship. Report Form

MAB Solut. MABSolys Génopole Campus 1 5 rue Henri Desbruères Evry Cedex. is involved at each stage of your project

Cytotoxic and Biotherapies Credentialing Programme Module 2

Outline. Predictive Assays in Radiation Therapy Immunotherapy in Cancer Treatment. Introduction. Current clinical practice

SmartFlare RNA Detection Probes: Principles, protocols and troubleshooting

PRINIPLES OF RADIATION THERAPY Adarsh Kumar. The basis of radiation therapy revolve around the principle that ionizing radiations kill cells

Supplemental Information. McBrayer et al. Supplemental Data

Recombinant DNA and Biotechnology

S1 Text. Modeling deterministic single-cell microrna-p53-mdm2 network Figure 2 Figure 2

Transfection-Transfer of non-viral genetic material into eukaryotic cells. Infection/ Transduction- Transfer of viral genetic material into cells.

A. FSC and SSC gating of total BM cells. B. Gating strategy used to identify the Lin -

Classical drug resistance in the molecular age

A role of microrna in the regulation of telomerase? Yuan Ming Yeh, Pei Rong Huang, and Tzu Chien V. Wang

Making the switch to a safer CAR-T cell therapy

Instructions. Torpedo sirna. Material. Important Guidelines. Specifications. Quality Control

NyONE - Cell imaging in a bird s eye view 4. NyONE...resolution matters! 8. Features & benefits 10. Fluorescence excitation channels 12

TECHNICAL INSIGHTS TECHNOLOGY ALERT

MicroRNA Mike needs help to degrade all the mrna transcripts! Aaron Arvey ISMB 2010

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294

Z-Stacking and Z-Projection using a Scaffold-based 3D Cell Culture Model

Cellulär och molekylär respons på låga doser av joniserande strålning

Evalution the multiplexed analysis of biomarkers made fast and simple by MyCartis

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

Relative Quantification of mirna Target mrnas by Real-Time qpcr. 1 Introduction. Gene Expression Application Note No. 4

On the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma

Chapter 8. Summary and Perspectives

QuickTiter Hepatitis B Surface Antigen (HBsAg) ELISA Kit

EXPRESSION ARREST shrna mir GENOME- WIDE LIBRARIES

Mir-X mirna First-Strand Synthesis Kit User Manual

mirnaselect pep-mir Cloning and Expression Vector

LightSwitch Luciferase Assay System

JIANGSU CARTMAY INDUSTRIAL CO.,LTD mail:

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

PROTOCOL. Immunostaining for Flow Cytometry. Background. Materials and equipment required.

The Need for a PARP in vivo Pharmacodynamic Assay

Overview of Phase 1 Oncology Trials of Biologic Therapeutics

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance

A Local Stability of Mathematical Models for Cancer Treatment by Using Gene Therapy

Looking Your Best on Paper. Lauren Celano Ph:

IKDT Laboratory. IKDT as Service Lab (CRO) for Molecular Diagnostics

R. Julian Preston NHEERL U.S. Environmental Protection Agency Research Triangle Park North Carolina. Ninth Beebe Symposium December 1, 2010

Cellular Implants as mini-factories for the production of therapeutic antibodies against Altzheimer s disease. rapport research week Jonas Schiffmann

Comparison of Trypan Blue and Fluorescence-Based Viability Detection Methods Via Morphological Observation

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

ELITE Custom Antibody Services

TEXT PICTURE. Martin Puhr PhD. Medical University of Innsbruck. Department of Urology Division of Experimental Urology

use. 3,5 Apoptosis Viability Titration Assays

RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES

Lezioni Dipartimento di Oncologia Farmacologia Molecolare. RNA interference. Giovanna Damia 29 maggio 2006

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

CFSE Cell Division Assay Kit

NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds

Introduction To Real Time Quantitative PCR (qpcr)

Virological Methods. Flint et al. Principles of Virology (ASM), Chapter 2

An Introduction To Immunotherapy And The Promise Of Tissue Phenomics

QuickTiter FeLV Core Antigen ELISA Kit (FeLV p27)

Essentials of Real Time PCR. About Sequence Detection Chemistries

RNA Viruses. A Practical Approac h. Alan J. Cann

Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO

RAPAd mirna Adenoviral Expression System Catalog #: VPK-253

How To Get A Cell Print

RNAi. Martin Latterich

HBV Quantitative Real Time PCR Kit

Uses of Flow Cytometry

Fighting the Battles: Conducting a Clinical Assay

Human Free Testosterone(F-TESTO) ELISA Kit

The RNA strategy. RNA as a tool and target in human disease diagnosis and therapy.

ab Propidium Iodide Flow Cytometry Kit for Cell Cycle Analysis

Genomic DNA Extraction Kit INSTRUCTION MANUAL

Appendix 2 Molecular Biology Core Curriculum. Websites and Other Resources

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Suppl. Figure 1. Cells cultured in oxldl take up Oil Red O in a time-dependent

No Disclosures. Learning Objectives 10/25/13

CD22 Antigen Is Broadly Expressed on Lung Cancer Cells and Is a Target for Antibody-Based Therapy

A Genetic Analysis of Rheumatoid Arthritis

Cell, Tissue and Tumor Kinetics

CytoSelect Cell Viability and Cytotoxicity Assay Kit

bitter is de pil Linos Vandekerckhove, MD, PhD

Chapter 18 Regulation of Gene Expression

Radiation Oncology Nursing Care. Helen Lusby Radiation Oncology Nurse BAROC 2012

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

Transcription:

CASE STUDY High Content Image Analysis Inhibition of MicroRNA Sensitizes 3D Breast Cancer Microtissues to Radiation Therapy Dr. Nataša Anastasov leads the Personalized Radiation Therapy Group within the Institute of Radiation Biology at the Helmholtz Center Munich. The group investigates tumor cell responses to ionizing radiation at the molecular, cellular and physiological level. Their research is contributing to the design of new strategies for the treatment of cancer. Radiation therapy (radiotherapy) plays an important role in the treatment of breast cancer. It is mostly applied after surgery of the primary breast tumor to prevent tumor recurrence. However, two key problems of radiotherapy remain unresolved; the intrinsic radioresistance of some cancer cells and the occurrence of chronic health problems in collaterally irradiated tissue, although modern therapies do aim to reduce these side effects by limiting the area of the patient's body exposed to radiation. Strategies to improve the therapeutic impact of radiotherapy include increasing the efficacy of radiation, for example through the development of radiosensitizers, and reducing the side effects through the use of radioprotective agents. 1

MicroRNAs (mirnas) are small non-coding RNA molecules involved in the transcriptional and post-transcriptional regulation of gene expression. They function by regulating the stability and translational efficiency of target messenger RNA (mrna) molecules. 2 Altered expression of mirnas has been demonstrated for several cancers, including breast cancer, and it has been suggested that mirnas may be involved in the activation of signaling pathways and apoptosis. 3,4 Dr. Anastasov s group also recently showed that, in breast cancer cells, expression of an mirna called mir-21 may contribute to radiation resistance by compromising cell cycle progression. 5 This case study describes an investigation by researchers within the Personalized Radiation Therapy Group into the radiosensitizing potential of mir-21 down-regulation, using T47D breast cancer cells and T47D 3D breast cancer microtissues (InSphero AG). 3D tumor microtissues are widely accepted as being more physiologically relevant than conventional 2D monolayer cell cultures, and can therefore help generate more predictive data. 6 Experimental Overview Experiments were performed using radiation-resistant T47D breast cancer cells cultured as either a conventional 2D culture, or as a 3D microtissue. A lentivirus-based transduction system was used to modulate mir-21 expression, as previously described by Anastasov et al., 2012. 5 Briefly, the pgreenpuro vector (pgp; System Biosciences, Inc.) encoding GFP was used as the backbone for specific mirna oligonucleotide cloning. Vector inserts encoded either the mir-21 sequence, to over-express mir-21 (mir-21), or a short hairpin RNA (shrna) targeting mir-21, to down-regulate expression of mir-21 (anti-mir-21). An empty pgp vector served as a negative control (EV = empty virus). For transduction, T47D cells were infected with 2 MOI (multiplicity of infection) of virus particles. Cell cultures were irradiated at room temperature using a 137 Cs irradiator (HWM-D 2000, Siemens, Germany). 5 mir-21 Inhibition Induces Apoptosis in Irradiated 2D Cancer Cells In the first experiment, to test the radiosensitizing potential of mir-21 over-expression or inhibition, 2D cultures of T47D cells were transduced with the different lentivirus types (EV, mir-21 or anti-mir-21) and irradiated with sham irradiation (0 Gy, control cells) or a dose of 5 Gy. Microscopic analysis of the cultures was performed 48 hr post-irradiation using phase contrast microscopy (Fig 1A). Cells in the control culture appear healthy and undisturbed, as do irradiated cells infected with EV, as a result of their radioresistance. Whilst over-expression of mir-21 has only a minor effect on the morphology of irradiated cells (+5 Gy, +mir-21), the expression of anti-mir-21 causes cells to become rounded following irradiation (+5 Gy, +anti-mir-21). Downregulation of mir-21 therefore has a serious effect on cell health when combined with irradiation. Figure 1. Inhibition of mir-21 induces apoptosis in irradiated 2D cultured T47D cancer cells. Radiation-resistant T47D breast cancer cells were transfected with different types of lentiviruses (EV = empty virus, mir-21 = over-expression of mir-21, anti-mir-21 = inhibition of mir-21) followed by sham irradiation (0 Gy, control) or irradiation with a dose of 5 Gy. (A) Phase contrast microscopic analysis of cells 48 hr post-irradiation. (B) DNA content analysis using flow cytometry 24 hr post irradiation. Cells with a DNA content less than G1 cells (<2n) were considered to be apoptotic. 2

To understand the effect of mir-21 on the cell cycle of 2D cultured T47D cells under the various treatment conditions, cells were stained with the DNA specific dye propidium iodide and a DNA content analysis was performed using flow cytometry. Under control conditions, irradiation induces a cell cycle arrest at the G2/M checkpoint in 2D T47D cells. Down-regulation of mir-21 (anti-mir-21), however, leads to a loss of radiation-induced G2/M arrest (data not shown). 5 The mir-21 knockdown also induces apoptosis in irradiated cells, as shown by quantitative analysis of the fraction of cells with a DNA content of less than G1 cells (<2n), which were considered to be apoptotic (Fig 1B). These results suggest a synergistic effect of mir-21 inhibition with radiotherapy. mir-21 Inhibition Impairs Growth of Irradiated 3D T47D Microtissues To investigate more physiologically relevant conditions, T47D cells were transfected with the three different lentivirus types and incubated for three days. Microtissues were then generated by seeding cells into the Insphero Gravity Plus plate (500 cells/well) and maturing them for two days in hanging drops, followed by transfer of the spheroids into Gravity TRAP assay plates. After one day of recovery, tissues were sham irradiated (0 Gy) or irradiated with a dose of 5 Gy. Imaging was performed at different timepoints post-irradiation, over a two week period, using the Operetta High Content Imaging System. Images from a single plane were acquired in the GFP and brightfield channels using the 10x NA objective in widefield mode (Fig 2A). Automated quantitative analysis of microtissue sizes at the different timepoints was then performed using Harmony High Content Imaging and Analysis Software. The Find Image Region Building Block was applied to the GFP channel to detect the microtissues in the well and then the Calculate Morphology Building Block was added to calculate the tissue area (µm 2 ) as the final readout (Fig 2B). Figure 2. Inhibition of mir-21 impairs growth of irradiated 3D T47D microtissues. Radiation-resistant T47D breast cancer cells were transfected with different types of lentiviruses (EV = empty virus, mir-21 = over-expression of mir-21, anti-mir-21 = inhibition of mir-21) and seeded into Gravity Plus plates to form microtissues. Mature microtissues were transferred into Gravity TRAP assay plates and were either sham irradiated (0 Gy, control) or irradiated with a dose of 5 Gy. Microtissue growth was analyzed every three days over a two week period. (A) High Content Imaging of microtissues in the GFP and brightfield channel using the Operetta High Content Imaging System (10x NA, single plane, widefield mode). (B) Quantitative analysis of microtissue size (area in µm 2 ) using the Harmony High Content Imaging and Analysis Software. While the non-irradiated control tissues (+EV, 0 Gy) showed constant growth over the two week time period, the irradiated tissues (+EV, 5 Gy) showed only a moderate growth. This is most likely due to cell cycle arrest at the G2/M checkpoint, which controls DNA integrity, since radiation-induced G2/M arrest is a well-known effect of radiation therapy. 5 Irradiation is therefore clearly impairing the growth of 3D microtissues. Tissues over-expressing mir-21 show a comparable growth rate to that of irradiated tissues transfected with empty virus, suggesting that mir-21 over-expression has no significant impact on the cell cycle. On the contrary, irradiation shows a strong inhibitory effect on microtissue growth in cells expressing anti-mir-21. In fact, these tissues even show a size reduction over time, suggesting that the cells in the microtissue may be undergoing apoptosis or might die during the experiment (Fig 2B). 3

mir-21 Inhibition Induces Apoptosis of Irradiated 3D T47D Microtissues To determine whether cells in the microtissue undergo apoptosis, an M30 Apoptosense ELISA (PEVIVA ; TECOmedical AG) was performed using the microtissue supernatant. The M30 Apoptosense is an ELISA based on a M30 monoclonal antibody which specifically binds caspase-cleaved keratin 18 (K18), a soluble human intermediate filament protein fragment. This assay therefore allows the measurement of apoptosis of K18- expressing cells. T47D cells were transfected with the different GFP-lentiviruses, cultured as 3D microtissues, and irradiated as described previously. Aliquots (30 µl) from the microtissue supernatants were collected immediately after irradiation (0 d), after six days, and after 12 days, from separate wells, and the ELISA performed. The colorimetric reaction was measured at 450 nm using a microplate reader. The resulting absorbance is directly proportional to the concentration of the K18 analyte. To determine apoptotic induction, a standard curve was plotted from known antigen concentrations versus measured absorbance. The induction of apoptosis was calculated in units per milliliters (U/ml). When comparing the different apoptosis levels in the non-irradiated microtissues (0 Gy), it is clear that mir-21 over-expression has no significant effect on the level of apoptosis, while inhibition of mir-21 by anti-mir-21 induces apoptosis (Fig 3, upper panel). When the microtissues are irradiated (5 Gy), this effect becomes even more pronounced (Fig 3, lower panel). In combination with irradiation, anti-mir-21 expression strongly induces apoptosis, particularly 12 days post-irradiation. This strongly indicates a synergistic effect of mir-21 inhibition and radiation therapy. Figure 3. Inhibition of mir-21 induces apoptosis of irradiated 3D T47D microtissues. Radiation-resistant T47D breast cancer cells were infected with different types of lentiviruses (control = cells without lentiviral infection, + EV = infected with empty virus, + mir-21 = over-expression of mir-21, + anti-mir-21 = inhibition of mir-21) and seeded into Gravity Plus plates to form microtissues. Mature microtissues were transferred into Gravity TRAP assay plates and were either sham irradiated (0 Gy, upper panel) or irradiated with a dose of 5 Gy (lower panel). To test for apoptosis, aliquots of the microtissue supernatants were taken at different timepoints post-irradiation (0 d, 6 d and 12 d) and submitted to a M30 Apoptosense ELISA. The Operetta System and Harmony Software make it easy for radiation biologists such as myself to translate biology into unbiased quantitative data and to use alternative approaches to the classical colony formation assays, such as more sophisticated microtissue assays. To investigate radiation resistance, we need long term analysis of cultures following treatment, which is not easy with standard 2D monolayer cultures. These new cutting-edge technologies will contribute tremendously to the optimization of personalized treatment strategies for cancer patients. - Dr. Nataša Anastasov Conclusion It has been previously suggested by Dr. Anastasov and colleagues that mir-21 knockdown and radiation therapy might have a synergistic effect in overcoming the radiation resistance of tumors. 5 In this case study, mir-21 was further confirmed as a potential target in breast cancer therapy by verification of the results obtained from a 2D culture, in a 3D environment, in 3D T47D breast cancer microtissues. Cells in microtissues have a more physiologically-relevant microenvironment and more closely resemble in vivo solid tumors. 6 As this case study demonstrates, microtissues are also a very good model system to study the radiation sensitivity of tumors and to test new strategies for either increasing radiation efficacy (radiosensitizers) or reducing the side effects of radiotherapy (radioprotectors), to further optimize patient care. Using the Operetta High Content Imaging System, the growth of microtissues was easily monitored by capturing the whole well of the Gravity TRAP plate using the 10x NA objective, followed by automatic analysis of tissue size over a two week time period with the Harmony High Content Imaging and Analysis Software. This case study exemplifies the combination of cutting-edge technologies such as shrna, lentiviral transduction, 3D microtissues and high content imaging and analysis. Together, these technologies can contribute to the development of more personalized treatment strategies for cancer patients. 4

Acknowledgements Many thanks to Dr. Nataša Anastasov from the Institute of Radiation Biology, Helmholtz Center Munich, and to her colleagues Dr. Ines Höfig, Dr. Ina Rothenaigner and Dr. Kamyar Hadian for providing the data for this case study. Thanks also to Dr. Karin Boettcher (PerkinElmer) and Dr. Sarah Piper (PerkinElmer) for writing the manuscript. References 1. Anastasov, N., Hoefig, I., Lichtenberg, J., Ströbel, S., Salomon, M., Thirion, C., Kelm, J., et al. (2013). Identification of compounds modifying radiation-therapy using a 3D-microtissue technology. AACR conference poster, 1. Retrieved from http://www.insphero.com/images/dokumente/ pdf/newsevents/aacr2013posterinspherohelmholtzsirion.pdf 2. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136 (2), 215 233. 3. Iorio, M. V, Ferracin, M., Liu, C. G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Research, 65 (16), 7065 7070. 4. Chaudhry, M. A. (2009). Real-time PCR analysis of micro-rna expression in ionizing radiation-treated cells. Cancer Biotherapy and Radiopharmaceuticals, 24 (1), 49 56. 5. Anastasov, N., Höfig, I., Vasconcellos, I. G., Rappl, K., Braselmann, H., Ludyga, N., Auer, G., et al. (2012). Radiation resistance due to high expression of mir-21 and G2/M checkpoint arrest in breast cancer cells. Radiation Oncology, 7 (1), 206. 6. Pampaloni, F., Reynaud, E. G., and Stelzer, E. H. K. (2007). The third dimension bridges the gap between cell culture and live tissue. Nature Reviews Molecular Cell Biology, 8 (10), 839 845. PerkinElmer, Inc. 940 Winter Street Waltham, MA 02451 USA P: (800) 762-4000 or (+1) 203-925-4602 www.perkinelmer.com For a complete listing of our global offices, visit www.perkinelmer.com/contactus Copyright 2013-2014, PerkinElmer, Inc. All rights reserved. PerkinElmer is a registered trademark of PerkinElmer, Inc. All other trademarks are the property of their respective owners. 011487_01 July 2014